Overview Nexium Dyspepsia/AST Status: Completed Trial end date: 2005-01-01 Target enrollment: Participant gender: Summary The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment period of 7 weeks. Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: Esomeprazole